Would you or your child like to experience using the Omnipod 5 patch pump?
We are looking for participants aged 2 – 24 years, who have been living with type 1 diabetes (T1D) for more than 12 months and are currently using either insulin injections or tubed insulin pump to manage their diabetes.
OPAL 2 study is a six-month randomised controlled trial to compare the experience of using the Omnipod 5, compared to using injections or tubed pump. The good news is that every participant will have the opportunity to trial using the Omnipod 5, either during the study period or for three months after.
To find out more about this study, please email Julie at diabetes.research@health.wa.gov.au